• BARD1 to raise up to $3.3 million via an Entitlement Issue at $0.02 per share • 1 for 5 pro rata non-renounceable entitlement issue to eligible shareholders • Funds intended to be used to advance development of the BARD1 diagnostics pipeline, ongoing research activities, commercial initiatives and for general working capital purposes
Ann: Non-Renounceable Issue, page-14
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $60.78M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 55.0¢ | 53.0¢ | $31.22K | 57.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18567 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 1867 | 1 |
View Market Depth
| Last trade - 14.06pm 11/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |